Astaxanthin supplementation combined with CrossFit exercise significantly improves adipokine function in men with obesity, mitigating complications and enhancing metabolic health, a new study concludes.
Short-term astaxanthin supplementation provided immune support for runners during rigorous exercise and uniquely countered decreases in plasma immunoglobulin levels, according to a recent study. It did not, however, offset exercise-induced muscle soreness,...
An astaxanthin-rich whole algae ingredient showed significant immune system benefits in a cohort of healthy young subjects competing in recreational running events.
New research from the Institute of Intelligent Machines (IIM), Hefei Institutes of Physical Science (HFIPS) in China found that the γ-aminobutyric acid (GABA) can promote the growth of Haematococcus pluvialis and increase the astaxanthin accumulation.
Algae Health Sciences, Inc. has announced it has joined the ranks of astaxanthin suppliers that have achieved Non GMO Project Verified status on its ingredients.
Israel’s Algatechnologies Ltd. has achieved Non-GMO Project verification for its 100% organic Haematococcus pluvialis microalgae powder and astaxanthin oleoresin.
Israel’s Algatechnologies is targeting a Q3 launch for a new algae-derived ingredient, with more launches to follow in 2018, the company’s director of marketing and sales told NutraIngredients-USA.
A new player has entered the astaxanthin market as Chinese ingredient supplier BGG has formed a subsidiary named Algae Life Sciences to market the carotenoid produced from a facility in Yunnan province.
Algatechnologies Ltd. has announced an R&D deal with German company SCHOTT AG to boost the productivity of its closed-tube cultivation system at its plant in the Negev region of southern Israel.
Fuji Chemical Industry Co. is shutting down astaxanthin production at its Hawaiian facility, meaning its total production of the algae-sourced antioxidant will occur at its Swedish base which runs by the name of BioReal.
BioReal has been given the green light to market its AstaREAL L-10
for supplements in Europe, after the astaxanthin was found to be
substantially equivalent to other sources on the market under
novels foods legislation.
A survey by Mera Pharmaceuticals has found that its
microalgae-derived supplement, AstaFactor, could act as an
anti-inflammatory agent. The primary ingredient, astaxanthin, is
also a powerful antioxidant.
